ARCHIVES

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

Clinical Trials Approved By NCI

November 28, 2003

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002